Copyright Reports & Markets. All rights reserved.

Global Drug Delivery Devices Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drug Delivery Devices by Type
    • 1.3.1 Overview: Global Drug Delivery Devices Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Drug Delivery Devices Consumption Value Market Share by Type in 2024
    • 1.3.3 Injection Type
    • 1.3.4 Mucosal Type
    • 1.3.5 Implanted Type
    • 1.3.6 Others Type
  • 1.4 Global Drug Delivery Devices Market by Application
    • 1.4.1 Overview: Global Drug Delivery Devices Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pharmaceutical Companies
    • 1.4.3 Hospitals
    • 1.4.4 Clinics
    • 1.4.5 Other
  • 1.5 Global Drug Delivery Devices Market Size & Forecast
  • 1.6 Global Drug Delivery Devices Market Size and Forecast by Region
    • 1.6.1 Global Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Drug Delivery Devices Market Size by Region, (2020-2031)
    • 1.6.3 North America Drug Delivery Devices Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Drug Delivery Devices Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Drug Delivery Devices Market Size and Prospect (2020-2031)
    • 1.6.6 South America Drug Delivery Devices Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Drug Delivery Devices Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Cipla
    • 2.1.1 Cipla Details
    • 2.1.2 Cipla Major Business
    • 2.1.3 Cipla Drug Delivery Devices Product and Solutions
    • 2.1.4 Cipla Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Cipla Recent Developments and Future Plans
  • 2.2 Baxter International
    • 2.2.1 Baxter International Details
    • 2.2.2 Baxter International Major Business
    • 2.2.3 Baxter International Drug Delivery Devices Product and Solutions
    • 2.2.4 Baxter International Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Baxter International Recent Developments and Future Plans
  • 2.3 Nipro Corporation
    • 2.3.1 Nipro Corporation Details
    • 2.3.2 Nipro Corporation Major Business
    • 2.3.3 Nipro Corporation Drug Delivery Devices Product and Solutions
    • 2.3.4 Nipro Corporation Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Nipro Corporation Recent Developments and Future Plans
  • 2.4 Roche
    • 2.4.1 Roche Details
    • 2.4.2 Roche Major Business
    • 2.4.3 Roche Drug Delivery Devices Product and Solutions
    • 2.4.4 Roche Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Roche Recent Developments and Future Plans
  • 2.5 Boehringer Ingelheim
    • 2.5.1 Boehringer Ingelheim Details
    • 2.5.2 Boehringer Ingelheim Major Business
    • 2.5.3 Boehringer Ingelheim Drug Delivery Devices Product and Solutions
    • 2.5.4 Boehringer Ingelheim Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.6 Allergan
    • 2.6.1 Allergan Details
    • 2.6.2 Allergan Major Business
    • 2.6.3 Allergan Drug Delivery Devices Product and Solutions
    • 2.6.4 Allergan Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Allergan Recent Developments and Future Plans
  • 2.7 3M
    • 2.7.1 3M Details
    • 2.7.2 3M Major Business
    • 2.7.3 3M Drug Delivery Devices Product and Solutions
    • 2.7.4 3M Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 3M Recent Developments and Future Plans
  • 2.8 BD
    • 2.8.1 BD Details
    • 2.8.2 BD Major Business
    • 2.8.3 BD Drug Delivery Devices Product and Solutions
    • 2.8.4 BD Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 BD Recent Developments and Future Plans
  • 2.9 Catalent
    • 2.9.1 Catalent Details
    • 2.9.2 Catalent Major Business
    • 2.9.3 Catalent Drug Delivery Devices Product and Solutions
    • 2.9.4 Catalent Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Catalent Recent Developments and Future Plans
  • 2.10 Valeant Pharmaceuticals
    • 2.10.1 Valeant Pharmaceuticals Details
    • 2.10.2 Valeant Pharmaceuticals Major Business
    • 2.10.3 Valeant Pharmaceuticals Drug Delivery Devices Product and Solutions
    • 2.10.4 Valeant Pharmaceuticals Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Valeant Pharmaceuticals Recent Developments and Future Plans
  • 2.11 Bayer AG
    • 2.11.1 Bayer AG Details
    • 2.11.2 Bayer AG Major Business
    • 2.11.3 Bayer AG Drug Delivery Devices Product and Solutions
    • 2.11.4 Bayer AG Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Bayer AG Recent Developments and Future Plans
  • 2.12 Chiesi
    • 2.12.1 Chiesi Details
    • 2.12.2 Chiesi Major Business
    • 2.12.3 Chiesi Drug Delivery Devices Product and Solutions
    • 2.12.4 Chiesi Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Chiesi Recent Developments and Future Plans
  • 2.13 Phillips-Medisize
    • 2.13.1 Phillips-Medisize Details
    • 2.13.2 Phillips-Medisize Major Business
    • 2.13.3 Phillips-Medisize Drug Delivery Devices Product and Solutions
    • 2.13.4 Phillips-Medisize Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Phillips-Medisize Recent Developments and Future Plans
  • 2.14 Johnson & Johnson
    • 2.14.1 Johnson & Johnson Details
    • 2.14.2 Johnson & Johnson Major Business
    • 2.14.3 Johnson & Johnson Drug Delivery Devices Product and Solutions
    • 2.14.4 Johnson & Johnson Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.15 Shandong Weigao
    • 2.15.1 Shandong Weigao Details
    • 2.15.2 Shandong Weigao Major Business
    • 2.15.3 Shandong Weigao Drug Delivery Devices Product and Solutions
    • 2.15.4 Shandong Weigao Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Shandong Weigao Recent Developments and Future Plans
  • 2.16 Pfizer
    • 2.16.1 Pfizer Details
    • 2.16.2 Pfizer Major Business
    • 2.16.3 Pfizer Drug Delivery Devices Product and Solutions
    • 2.16.4 Pfizer Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Pfizer Recent Developments and Future Plans
  • 2.17 B.Braun
    • 2.17.1 B.Braun Details
    • 2.17.2 B.Braun Major Business
    • 2.17.3 B.Braun Drug Delivery Devices Product and Solutions
    • 2.17.4 B.Braun Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 B.Braun Recent Developments and Future Plans
  • 2.18 Novartis AG
    • 2.18.1 Novartis AG Details
    • 2.18.2 Novartis AG Major Business
    • 2.18.3 Novartis AG Drug Delivery Devices Product and Solutions
    • 2.18.4 Novartis AG Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Novartis AG Recent Developments and Future Plans
  • 2.19 Zhengkang
    • 2.19.1 Zhengkang Details
    • 2.19.2 Zhengkang Major Business
    • 2.19.3 Zhengkang Drug Delivery Devices Product and Solutions
    • 2.19.4 Zhengkang Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Zhengkang Recent Developments and Future Plans
  • 2.20 Gerresheimer
    • 2.20.1 Gerresheimer Details
    • 2.20.2 Gerresheimer Major Business
    • 2.20.3 Gerresheimer Drug Delivery Devices Product and Solutions
    • 2.20.4 Gerresheimer Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Gerresheimer Recent Developments and Future Plans
  • 2.21 COVIDIEN Medtronic
    • 2.21.1 COVIDIEN Medtronic Details
    • 2.21.2 COVIDIEN Medtronic Major Business
    • 2.21.3 COVIDIEN Medtronic Drug Delivery Devices Product and Solutions
    • 2.21.4 COVIDIEN Medtronic Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.21.5 COVIDIEN Medtronic Recent Developments and Future Plans
  • 2.22 Schott forma vitrum
    • 2.22.1 Schott forma vitrum Details
    • 2.22.2 Schott forma vitrum Major Business
    • 2.22.3 Schott forma vitrum Drug Delivery Devices Product and Solutions
    • 2.22.4 Schott forma vitrum Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.22.5 Schott forma vitrum Recent Developments and Future Plans
  • 2.23 Alkermes
    • 2.23.1 Alkermes Details
    • 2.23.2 Alkermes Major Business
    • 2.23.3 Alkermes Drug Delivery Devices Product and Solutions
    • 2.23.4 Alkermes Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.23.5 Alkermes Recent Developments and Future Plans
  • 2.24 Skyepharma
    • 2.24.1 Skyepharma Details
    • 2.24.2 Skyepharma Major Business
    • 2.24.3 Skyepharma Drug Delivery Devices Product and Solutions
    • 2.24.4 Skyepharma Drug Delivery Devices Revenue, Gross Margin and Market Share (2020-2025)
    • 2.24.5 Skyepharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drug Delivery Devices Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Drug Delivery Devices by Company Revenue
    • 3.2.2 Top 3 Drug Delivery Devices Players Market Share in 2024
    • 3.2.3 Top 6 Drug Delivery Devices Players Market Share in 2024
  • 3.3 Drug Delivery Devices Market: Overall Company Footprint Analysis
    • 3.3.1 Drug Delivery Devices Market: Region Footprint
    • 3.3.2 Drug Delivery Devices Market: Company Product Type Footprint
    • 3.3.3 Drug Delivery Devices Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drug Delivery Devices Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Drug Delivery Devices Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Drug Delivery Devices Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Drug Delivery Devices Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Drug Delivery Devices Consumption Value by Type (2020-2031)
  • 6.2 North America Drug Delivery Devices Market Size by Application (2020-2031)
  • 6.3 North America Drug Delivery Devices Market Size by Country
    • 6.3.1 North America Drug Delivery Devices Consumption Value by Country (2020-2031)
    • 6.3.2 United States Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Drug Delivery Devices Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Drug Delivery Devices Consumption Value by Type (2020-2031)
  • 7.2 Europe Drug Delivery Devices Consumption Value by Application (2020-2031)
  • 7.3 Europe Drug Delivery Devices Market Size by Country
    • 7.3.1 Europe Drug Delivery Devices Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 7.3.3 France Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Drug Delivery Devices Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drug Delivery Devices Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Drug Delivery Devices Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Drug Delivery Devices Market Size by Region
    • 8.3.1 Asia-Pacific Drug Delivery Devices Consumption Value by Region (2020-2031)
    • 8.3.2 China Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 8.3.5 India Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Drug Delivery Devices Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Drug Delivery Devices Consumption Value by Type (2020-2031)
  • 9.2 South America Drug Delivery Devices Consumption Value by Application (2020-2031)
  • 9.3 South America Drug Delivery Devices Market Size by Country
    • 9.3.1 South America Drug Delivery Devices Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Drug Delivery Devices Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drug Delivery Devices Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Drug Delivery Devices Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Drug Delivery Devices Market Size by Country
    • 10.3.1 Middle East & Africa Drug Delivery Devices Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Drug Delivery Devices Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Drug Delivery Devices Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Drug Delivery Devices Market Drivers
  • 11.2 Drug Delivery Devices Market Restraints
  • 11.3 Drug Delivery Devices Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drug Delivery Devices Industry Chain
  • 12.2 Drug Delivery Devices Upstream Analysis
  • 12.3 Drug Delivery Devices Midstream Analysis
  • 12.4 Drug Delivery Devices Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug Delivery Devices market size was valued at US$ 46830 million in 2024 and is forecast to a readjusted size of USD 64720 million by 2031 with a CAGR of 4.8% during review period.
    Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
    The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world"s research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
    This report is a detailed and comprehensive analysis for global Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug Delivery Devices market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Drug Delivery Devices market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug Delivery Devices
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug Delivery Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD, Catalent, Valeant Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Drug Delivery Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Injection Type
    Mucosal Type
    Implanted Type
    Others Type
    Market segment by Application
    Pharmaceutical Companies
    Hospitals
    Clinics
    Other
    Market segment by players, this report covers
    Cipla
    Baxter International
    Nipro Corporation
    Roche
    Boehringer Ingelheim
    Allergan
    3M
    BD
    Catalent
    Valeant Pharmaceuticals
    Bayer AG
    Chiesi
    Phillips-Medisize
    Johnson & Johnson
    Shandong Weigao
    Pfizer
    B.Braun
    Novartis AG
    Zhengkang
    Gerresheimer
    COVIDIEN Medtronic
    Schott forma vitrum
    Alkermes
    Skyepharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Drug Delivery Devices, with revenue, gross margin, and global market share of Drug Delivery Devices from 2020 to 2025.
    Chapter 3, the Drug Delivery Devices competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Delivery Devices market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Delivery Devices.
    Chapter 13, to describe Drug Delivery Devices research findings and conclusion.

    Buy now